Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with C9orf72 hexanucleotide repeat expansion

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433 · see citing works

Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria

Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047 · see citing works

Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS

DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · see citing works

A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD

Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409 · see citing works

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function

Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307 · see citing works

Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

Majounie, E., Renton, A. E., Mok, K., Dopper, E. G., Waite, A., Rollinson, S., Chiò, A., Restagno, G., Nicolaou, N., Simon-Sanchez, J., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70043-1 · Cited by 1,210 · see citing works

Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS

Ash, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T. R., Lin, W.-L., DeJesus‐Hernandez, M., van Blitterswijk, M., Jansen‐West, K. R., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,079 · see citing works

The UCH-L1 Gene Encodes Two Opposing Enzymatic Activities that Affect α-Synuclein Degradation and Parkinson's Disease Susceptibility

Liu, Y., Fallon, L., Lashuel, H. A., Liu, Z., & Lansbury, P. T. (2002) · Cell · doi:10.1016/s0092-8674(02)01012-7 · Cited by 786 · see citing works

Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases

Choi, J., Levey, A. I., Weintraub, S. T., Rees, H. D., Gearing, M., Chin, L.-S., & Li, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314124200 · Cited by 568 · see citing works

Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins

Mori, K., Arzberger, T., Grässer, F. A., Gijselinck, I., May, S., Rentzsch, K., Weng, S., Schludi, M. H., van der Zee, J., Cruts, M., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1189-3 · Cited by 482 · see citing works

Development of methodology for conducting clinical trials in frontotemporal lobar degeneration

Knopman, D. S., Kramer, J. H., Boeve, B. F., Caselli, R. J., Graff-Radford, N. R., Mendez, M. F., Miller, B. L., & Mercaldo, N. (2008) · Brain · doi:10.1093/brain/awn234 · Cited by 442 · see citing works

Transferrin receptor 1 in cancer: a new sight for cancer therapy.

Shen, Y., Li, X., Dong, D., Zhang, B., Xue, Y., & Shang, P. (2018) · Europe PMC (PubMed Central) · Cited by 357 · see citing works

Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients

Steinacker, P., Feneberg, E., Weishaupt, J. H., Brettschneider, J., Tumani, H., Andersen, P. M., Arnim, C. A. F. V., Böhm, S., Kassubek, J., Kubisch, C., et al. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311387 · Cited by 316 · see citing works

TREM2-Ligand Interactions in Health and Disease

Kober, D. L., & Brett, T. J. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.04.004 · Cited by 284 · see citing works

Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion

Waite, A. J., Bäumer, D., East, S. Z., Neal, J., Morris, H. R., Ansorge, O., & Blake, D. J. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.016 · Cited by 277 · see citing works

A Pan‐ E uropean Study of the C9orf72 Repeat Associated with FTLD : Geographic Prevalence, Genomic Instability, and Intermediate Repeats

van der Zee, J., Gijselinck, I., Dillen, L., Langenhove, T. V., Theuns, J., Engelborghs, S., Philtjens, S., Vandenbulcke, M., Sleegers, K., Sieben, A., et al. (2012) · Human Mutation · doi:10.1002/humu.22244 · Cited by 266 · see citing works

Dysregulation of Iron Homeostasis in the CNS Contributes to Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis

Jeong, S. Y., Rathore, K. I., Schulz, K., Ponka, P., Arosio, P., & David, S. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5443-08.2009 · Cited by 174 · see citing works

A proteomic network approach across the ALS‐FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain

Umoh, M. E., Dammer, E. B., Dai, J., Duong, D. M., Lah, J. J., Levey, A. I., Gearing, M., Glass, J. D., & Seyfried, N. T. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201708202 · Cited by 154 · see citing works

C9ORF72 interaction with cofilin modulates actin dynamics in motor neurons

Sivadasan, R., Hornburg, D., Drepper, C., Frank, N., Jablonka, S., Hansel, A., Lojewski, X., Sterneckert, J. L., Hermann, A., Shaw, P. J., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4407 · Cited by 148 · see citing works

Presynaptic neuronal pentraxin receptor organizes excitatory and inhibitory synapses

Lee, S.-J., Wei, M., Zhang, C., Maxeiner, S., Pak, C., Calado Botelho, S., Trotter, J., Sterky, F. H., & Südhof, T. C. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2768-16.2016 · Cited by 146 · see citing works

Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase

Oeckl, P., Weydt, P., Steinacker, P., Anderl-Straub, S., Nordin, F., Volk, A. E., Diehl-Schmid, J., Andersen, P. M., Kornhuber, J., Danek, A., et al. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-318868 · Cited by 139 · see citing works

Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis

Thompson, A. G., Gray, E., Thézénas, M., Charles, P. D., Evetts, S., Hu, M. T., Talbot, K., Fischer, R., Kessler, B. M., & Turner, M. R. (2018) · Annals of Neurology · doi:10.1002/ana.25143 · Cited by 130 · see citing works

Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression

Steinacker, P., Verde, F., Fang, L., Feneberg, E., Oeckl, P., Roeber, S., Anderl-Straub, S., Danek, A., Diehl-Schmid, J., Fassbender, K., et al. (2018) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317138 · Cited by 129 · see citing works

Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis

Oeckl, P., Weydt, P., Thal, D. R., Weishaupt, J. H., Ludolph, A. C., & Otto, M. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02093-x · Cited by 119 · see citing works

Progression of the role of CRYAB in signaling pathways and cancers

Zhang, J., Liu, J., Wu, J., Li, W., Chen, Z., & Yang, L. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s201799 · Cited by 118 · see citing works

Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity

Yang, C., Danielson, E., Qiao, T., Metterville, J., Brown, R. H., Landers, J. E., & Xu, Z. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605964113 · Cited by 107 · see citing works

CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders

Mondello, S., Constantinescu, R., Zetterberg, H., Andréasson, U., Holmberg, B., & Jeromin, A. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.01.011 · Cited by 98 · see citing works

Upregulation of alphaB-crystallin expression in the substantia nigra of patients with Parkinson's disease

Liu, Y., Zhou, Q., Tang, M., Fu, N., Shao, W., Zhang, S., Yin, Y., Zeng, R., Wang, X., Hu, G., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.01.015 · Cited by 81 · see citing works

Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls

Kroksveen, A. C., Guldbrandsen, A., Vedeler, C., Myhr, K. M., Opsahl, J. A., & Berven, F. S. (2012) · Acta Neurologica Scandinavica · doi:10.1111/ane.12029 · Cited by 80 · see citing works

Polymerase chain reaction and Southern blot-based analysis of the C9orf72 hexanucleotide repeat in different motor neuron diseases

Hübers, A., Marroquin, N., Schmoll, B., Vielhaber, S., Just, M., Mayer, B., Högel, J., Dorst, J., Mertens, T., Just, W., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.034 · Cited by 69 · see citing works

High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer’s Disease in Human Cerebrospinal Fluid

Hendrickson, R. C., Lee, A. Y. H., Song, Q., Liaw, A. I., Wiener, M., Paweletz, C. P., Seeburger, J. L., Li, J., Meng, F., Deyanova, E. G., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135365 · Cited by 68 · see citing works

C9ORF72 is a GDP/GTP exchange factor for Rab8 and Rab39 and regulates autophagy

Corbier, C., & Sellier, C. (2016) · Small GTPases · doi:10.1080/21541248.2016.1212688 · Cited by 68 · see citing works

Neurite density is reduced in the presymptomatic phase ofC9orf72disease

Wen, J., Zhang, H. G., Alexander, D. C., Durrleman, S., Routier, A., Rinaldi, D., Houot, M., Couratier, P., Hannequin, D., Pasquier, F., et al. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-318994 · Cited by 65 · see citing works

Novel <scp>CSF</scp> biomarkers in genetic frontotemporal dementia identified by proteomics

van der Ende, E. L., Meeter, L. H., Stingl, C., van Rooij, J. G. J., Stoop, M. P., Nijholt, D. A. T., Sanchez‐Valle, R., Graff, C., Öijerstedt, L., Grossman, M., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.745 · Cited by 65 · see citing works

Cell Adhesion Molecule Close Homolog of L1 (CHL1) Guides the Regrowth of Regenerating Motor Axons and Regulates Synaptic Coverage of Motor Neurons

Guseva, D., Jakovčevski, I., Irintchev, A., Leshchyns’ka, I., Sytnyk, V., Ponimaskin, E. G., & Schachner, M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00174 · Cited by 30 · see citing works

Gyrification abnormalities in presymptomatic <i>c9orf72</i> expansion carriers

Caverzasi, E., Battistella, G., Chu, S. A., Rosen, H., Zanto, T. P., Karydas, A., Shwe, W., Coppola, G., Geschwind, D. H., Rademakers, R., et al. (2019) · Journal of Neurology, Neurosurgery &amp; Psychiatry · doi:10.1136/jnnp-2018-320265 · Cited by 30 · see citing works

Liquid biopsy of cerebrospinal fluid identifies neuronal pentraxin receptor (NPTXR) as a biomarker of progression of Alzheimer’s disease

Lim, B., Tsolaki, M., Soosaipillai, A., Brown, M., Zilakaki, M., Tagaraki, F., Fotiou, D., Koutsouraki, E., Grosi, E., Prassas, I., et al. (2019) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-0428 · Cited by 25 · see citing works

Combined Transcriptomics and Proteomics in Frontal Cortex Area 8 in Frontotemporal Lobar Degeneration Linked to C9ORF72 Expansion

Andrés‐Benito, P., Gelpí, E., Povedano, M., Ausín, K., Fernández‐Irigoyen, J., Santamaría, E., & Ferrer, I. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181123 · Cited by 21 · see citing works

Characterization and tissue expression of a novel human gene npdc1

Qu, X., Zhang, C., Zhai, Y., Xing, G., Wei, H., Yu, Y., Wu, S., & He, F. (2001) · Gene · doi:10.1016/s0378-1119(01)00324-9 · Cited by 18 · see citing works

Subcellular localization of neural‐specific NPDC‐1 protein

Evrard, C., & Rouget, P. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20405 · Cited by 8 · see citing works

Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses

Béland, L.-C., Markovinovic, A., Jakovac, H., De Marchi, F., Bilic, E., Mazzini, L., Kriz, J., & Munitic, I. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa124 · Cited by 125 · see citing works

Fluid biomarkers in frontotemporal dementia: past, present and future

Swift, I. J., Sogorb-Esteve, A., Heller, C., Synofzik, M., Otto, M., Graff, C., Galimberti, D., Todd, E., Heslegrave, A. J., van der Ende, E. L., et al. (2021) · Journal of Neurology, Neurosurgery &amp; Psychiatry · doi:10.1136/jnnp-2020-323520 · Cited by 122 · see citing works

Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration

Gómez de San José, N., Massa, F., Halbgebauer, S., Oeckl, P., Steinacker, P., & Otto, M. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-021-02411-2 · Cited by 112 · see citing works

The role of inflammation in neurodegeneration: novel insights into the role of the immune system in C9orf72 HRE-mediated ALS/FTD

Masrori, P., Beckers, J., Gossye, H., & Damme, P. V. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00525-z · Cited by 72 · see citing works

Biomarkers in Neurodegenerative Diseases: Proteomics Spotlight on ALS and Parkinson’s Disease

Raghunathan, R., Turajane, K., & Wong, L. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169299 · Cited by 60 · see citing works

A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia

van der Ende, E. L., Bron, E. E., Poos, J. M., Jiskoot, L. C., Panman, J. L., Papma, J. M., Meeter, L. H. H., Dopper, E. G. P., Wilke, C., Synofzik, M., et al. (2021) · Brain · doi:10.1093/brain/awab382 · Cited by 56 · see citing works

Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis

Falzone, Y., Domi, T., Mandelli, A., Pozzi, L., Schito, P., Russo, T., Barbieri, A., Fazio, R., Volonté, M. A., Magnani, G., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15321 · Cited by 56 · see citing works

The presymptomatic phase of amyotrophic lateral sclerosis: are we merely scratching the surface?

Chipika, R. H., Siah, W. F., McKenna, M. C., Shing, S. L. H., Hardiman, O. M., & Bede, P. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10289-5 · Cited by 53 · see citing works

Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis

Katzeff, J. S., Bright, F., Phan, K., Kril, J. J., Ittner, L. M., Kassiou, M., Hodges, J. R., Piguet, O., Kiernan, M. C., Halliday, G. M., et al. (2022) · Brain · doi:10.1093/brain/awac077 · Cited by 48 · see citing works

Biomarkers for amyotrophic lateral sclerosis

Witzel, S., Mayer, K., & Oeckl, P. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001094 · Cited by 39 · see citing works

A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study

Bergström, S., Öijerstedt, L., Remnestål, J., Olofsson, J., Ullgren, A., Seelaar, H., Swieten, J. C. V., Synofzik, M., Sánchez‐Valle, R., Moreno, F., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00499-4 · Cited by 36 · see citing works

Discovery of Biomarkers for Amyotrophic Lateral Sclerosis from Human Cerebrospinal Fluid Using Mass-Spectrometry-Based Proteomics

Oh, S., Jang, Y., & Na, C. H. (2023) · Biomedicines · doi:10.3390/biomedicines11051250 · Cited by 34 · see citing works

Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder

Marchi, F. D., Franjkic, T., Schito, P., Russo, T., Nimac, J., Chami, A. A., Mele, A., Vidatic, L., Križ, J., Julien, J., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061599 · Cited by 28 · see citing works

Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants

Marchi, F. D., Tondo, G., Corrado, L., Menegon, F., Aprile, D., Anselmi, M., D’Alfonso, S., Comi, C., & Mazzini, L. (2023) · Genes · doi:10.3390/genes14081658 · Cited by 28 · see citing works

Biomarkers in frontotemporal dementia: Current landscape and future directions

Gifford, A., Praschan, N. C., Newhouse, A. L., & Chemali, Z. N. (2023) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2023.100065 · Cited by 26 · see citing works

Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis

Costa, J., Gromicho, M., Pronto‐Laborinho, A. C., Almeida, C., Gomes, R. A., Guerreiro, A. C. L., Oliva, A., Pinto, S., & de Carvalho, M. A. (2021) · Diagnostics · doi:10.3390/diagnostics11071210 · Cited by 23 · see citing works

Neurodegeneration Markers in the Cerebrospinal Fluid of 100 Patients with Schizophrenia Spectrum Disorder

Runge, K., Balla, A., Fiebich, B. L., Maier, S. J., von Zedtwitz, K., Nickel, K., Dersch, R. S., Domschke, K., van Elst, L. T., & Endres, D. (2022) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac135 · Cited by 19 · see citing works

Biomarkers for C9orf7-ALS in Symptomatic and Pre-symptomatic Patients: State-of-the-art in the New Era of Clinical Trials

Querin, G., Biferi, M. G., & Pradat, P. (2021) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-210754 · Cited by 20 · see citing works

Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer’s disease continuum

Paciotti, S., Wojdała, A. L., Bellomo, G., Toja, A., Chipi, E., Piersma, S. R., Pham, T. V., Gaetani, L., Jiménez, C. R., Parnetti, L., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01269-8 · Cited by 19 · see citing works

Protein biomarkers for the diagnosis and prognosis of Amyotrophic Lateral Sclerosis

Donini, L., Tanel, R., Zuccarino, R., & Basso, M. (2023) · Neuroscience Research · doi:10.1016/j.neures.2023.09.002 · Cited by 17 · see citing works

Breakdown of the central synapses in C9orf72-linked ALS/FTD

Ghaffari, L., Trotti, D., Haeusler, A. R., & Jensen, B. K. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1005112 · Cited by 15 · see citing works

Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes

Sogorb‐Esteve, A., Weiner, S., Simrén, J., Swift, I. J., Bocchetta, M., Todd, E. G., Cash, D. M., Bouzigues, A., Russell, L. L., Foster, P. H., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adm9654 · Cited by 15 · see citing works

Data‐independent acquisition proteomics of cerebrospinal fluid implicates endoplasmic reticulum and inflammatory mechanisms in amyotrophic lateral sclerosis

Dellar, E., Vendrell, I., Talbot, K., Kessler, B., Fischer, R., Turner, M. R., & Thompson, A. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.16030 · Cited by 12 · see citing works

Mass spectrometry based protein biomarkers and drug target discovery and clinical diagnosis in Age-Related progressing neurodegenerative diseases

Agrawal, I., Tripathi, P., & Biswas, S. (2022) · Drug Metabolism Reviews · doi:10.1080/03602532.2022.2029475 · Cited by 12 · see citing works

CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia

Woollacott, I., Swift, I. J., Sogorb‐Esteve, A., Heller, C., Knowles, K., Bouzigues, A., Russell, L. L., Peakman, G., Greaves, C. V., Convery, R. S., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51672 · Cited by 12 · see citing works

Novel CSF Biomarkers Tracking Autoimmune Inflammatory and Neurodegenerative Aspects of CNS Diseases

Kapaki, E. N., Vakrakou, A. G., & Boufidou, F. (2022) · Diagnostics · doi:10.3390/diagnostics13010073 · Cited by 11 · see citing works

Insights into disease mechanisms and potential therapeutics for C9orf72-related amyotrophic lateral sclerosis/frontotemporal dementia

Gagliardi, D., Costamagna, G., Taiana, M. M., Andreoli, L., Biella, F., Bersani, M., Bresolin, N., Comi, G. P., & Corti, S. P. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101172 · Cited by 11 · see citing works

Fluid Biomarkers of Frontotemporal Lobar Degeneration

van der Ende, E. L., & Swieten, J. C. V. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_9 · Cited by 10 · see citing works

Advancing mechanistic understanding and biomarker development in amyotrophic lateral sclerosis

Thompson, A. G., Oeckl, P., Feneberg, E., Bowser, R. P., Otto, M., Fischer, R., Kessler, B. M., & Turner, M. R. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.2004890 · Cited by 9 · see citing works

Elevated Cerebrospinal Fluid Ubiquitin Carboxyl‐Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion Carriers

Dellar, E. R., Vendrell, I., Amein, B., Lester, D., Edmond, E., Yoganathan, K. T., Dharmadasa, T., Sogorb‐Esteve, A., Fischer, R., Talbot, K., et al. (2024) · Annals of Neurology · doi:10.1002/ana.27133 · Cited by 7 · see citing works

Biomarkers in cerebrospinal fluid for amyotrophic lateral sclerosis phenotypes

Zhou, J., Zeng, Q., Liao, Q., Niu, Q., Gu, W., Su, D., Li, S., Xiao, B., & Bi, F. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51836 · Cited by 6 · see citing works

Cerebrospinal fluid levels of NfM in relation to NfL and pNfH as prognostic markers in amyotrophic lateral sclerosis

Olofsson, J., Bergström, S., Mravinacová, S., Kläppe, U., Öijerstedt, L., Zetterberg, H., Blennow, K., Ingre, C., Nilsson, P., & Månberg, A. (2024) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2428930 · Cited by 6 · see citing works

How can we define the presymptomatic C9orf72 disease in 2022? An overview on the current definitions of preclinical and prodromal phases

Saracino, D., & Ber, I. L. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2022.03.007 · Cited by 6 · see citing works

Comparative analysis of cerebrospinal fluid neurofilament medium, light and heavy chain in neurodegenerative diseases using an in-house assay for the detection of neurofilament medium chain

Fazeli, B., Botzenhardt, S., Bachhuber, F., Klassen, P., Klose, V., Dorst, J., Wiesenfarth, M., Uzelac, Ž., Jesse, S., Brenner, D., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105930 · Cited by 4 · see citing works

Diagnostic value of fluid‐based non‐amyloid biomarkers for Alzheimer's disease and related dementias in a clinic‐based cohort from South Asia

Arshad, F., Samim, M. M., Borse, P. R., Shankar, R. G., Bharath, R. D., Gagantej, B. H., Mailankody, P., Ramakrishnan, S., Subramanian, S., & Alladi, S. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70129 · Cited by 3 · see citing works

Therapeutic Potential of Antibody Targeting Neuronal Pentraxin Receptor in Esophageal Squamous Cell Carcinoma

Shinozuka, T., Kanda, M., Sato, Y., Shimizu, D., Umeda, S., Takami, H., Hattori, N., Hayashi, M., Tanaka, C., & Kodera, Y. (2024) · Annals of Surgical Oncology · doi:10.1245/s10434-024-15353-2 · Cited by 3 · see citing works

VGF and Its Derived Peptides in Amyotrophic Lateral Sclerosis

Manai, A. L., Caria, P., Noli, B., Contini, C., Manconi, B., Etzi, F., & Cocco, C. (2025) · Brain Sciences · doi:10.3390/brainsci15040329 · Cited by 3 · see citing works

The FindMNDBiomarker Program: Protein Changes in Motor Neuron Disease/Amyotrophic Lateral Sclerosis Postmortem Tissue and Biofluids

Adler, G. L., Kiernan, M. C., & Tan, R. H. (2025) · Annals of Neurology · doi:10.1002/ana.27300 · Cited by 2 · see citing works

Motor behavioral abnormalities and histopathological findings in middle aged male Wistar rats inoculated with cerebrospinal fluid from patients with Amyotrophic Lateral Sclerosis

de Gois, A. M., Bispo, J. M. M., Lins, L. C. R. F., Medeiros, K. A. A. L., Souza, M. F., Santos, E. R., Santos, J. F., Ribeiro, A. M., Silva, R. H., Paixão, M. D. O. R., et al. (2022) · Current Research in Behavioral Sciences · doi:10.1016/j.crbeha.2022.100069 · Cited by 1 · see citing works

Amyotrophic Lateral Sclerosis: Neurochemical Biomarkers

Verde, F., & Ticozzi, N. (2022) · Springer eBooks · doi:10.1007/978-3-031-06731-0_16 · Cited by 1 · see citing works

Identification of pathogenic C9orf72 hexanucleotide repeat expansion in a Chinese patient with frontotemporal dementia: A case report

Xue, Y., Wu, Z., & Li, H. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13639 · Cited by 1 · see citing works

Comparative analysis of cerebrospinal fluid neurofilament medium, light and heavy chain in neurodegenerative diseases using a novel assay for the detection of neurofilament medium chainPreprint

Fazeli, B., Botzenhardt, S., Bachhuber, F., Klassen, P., Klose, V., Dorst, J., Wiesenfarth, M., Uzelac, Ž., Jesse, S., Brenner, D., et al. (2025) · medRxiv · doi:10.1101/2025.01.20.25320650

Additional file 1 of Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer’s disease continuum

Paciotti, S., Wojdała, A. L., Bellomo, G., Toja, A., Chipi, E., Piersma, S. R., Pham, T. V., Gaetani, L., Jiménez, C. R., Parnetti, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23691223

Développement d’outils pour la caractérisation de la TDP-43 et exploration de marqueurs indirects dans un contexte de dégénérescence lobaire frontotemporale

Escal, J. (2021) · theses.fr (ABES) · doi:10.70675/c8b346f7zb4e3z43e0za63azb407baddab64

Multiplex Panel Detects Glial and Inflammatory Biomarker Signatures in Sporadic and C9orf72-ALS

Baskar, K., Steffke, C., Bernsen, S., Elmas, Z., Hesebeck‐Brinckmann, J., Schuster, J., Meyer, T., Weydt, P., Weishaupt, J. H., Brenner, D., et al. (2026) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200618

Elevated Cerebrospinal Fluid Ubiquitin Carboxyl‐Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion Carriers

Dellar, E. R., Vendrell, I., Amein, B., Lester, D., Edmond, E., Yoganathan, K. T., Dharmadasa, T., Sogorb‐Esteve, A., Fischer, R., Talbot, K., et al. (2024) · Annals of Neurology · doi:10.1002/ana.27133 · Cited by 7 · see citing works

Biomarkers for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Associated With Hexanucleotide Expansion Mutations in C9orf72

Floeter, M. K., & Gendron, T. F. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01063 · Cited by 33 · see citing works

A CSF Signature of Frontotemporal Lobar Degeneration with C9orf72 Repeat Expansions (S18.003)

Hu, W. T., Glass, J. D., Deerlin, V. M. V., Grossman, M., Watts, K. D., Lah, J. J., Trojanowski, J. Q., & Levey, A. I. (2014) · Neurology · doi:10.1212/wnl.82.10_supplement.s18.003

A CSF Signature of Frontotemporal Lobar Degeneration with C9orf72 Repeat Expansions (I11-1.003)

Hu, W. T., Glass, J. D., Deerlin, V. M. V., Grossman, M., Watts, K. D., Lah, J. J., Trojanowski, J. Q., & Levey, A. I. (2014) · Neurology · doi:10.1212/wnl.82.10_supplement.i11-1.003

The neuropathology of frontotemporal dementia and amyotrophic lateral sclerosis with a C9ORF72 hexanucleotide repeat expansion

Bieniek, K. F. (n.d.) · ProQuest Demo Repository